These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32194663)

  • 1. High expression levels of CLEC4M indicate poor prognosis in patients with hepatocellular carcinoma.
    Luo L; Chen L; Ke K; Zhao B; Wang L; Zhang C; Wang F; Liao N; Zheng X; Liu X; Wang Y; Liu J
    Oncol Lett; 2020 Mar; 19(3):1711-1720. PubMed ID: 32194663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CLEC4M overexpression inhibits progression and is associated with a favorable prognosis in hepatocellular carcinoma.
    Yu Q; Gao K
    Mol Med Rep; 2020 Sep; 22(3):2245-2252. PubMed ID: 32705212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
    Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
    BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low
    Cheng Y; Xing SG; Jia WD; Huang M; Bian NN
    Onco Targets Ther; 2017; 10():47-54. PubMed ID: 28031722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma.
    Xu L; Zhang M; Zheng X; Yi P; Lan C; Xu M
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):17-27. PubMed ID: 27614453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
    Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
    Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and prognostic significance of contactin 1 in human hepatocellular carcinoma.
    Li GY; Huang M; Pan TT; Jia WD
    Onco Targets Ther; 2016; 9():387-94. PubMed ID: 26855587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and clinical significance of Nectin-4 in hepatocellular carcinoma.
    Ma J; Sheng Z; Lv Y; Liu W; Yao Q; Pan T; Xu Z; Zhang C; Xu G
    Onco Targets Ther; 2016; 9():183-90. PubMed ID: 26793002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low levels of tumor suppressor candidate 3 predict poor prognosis of patients with hepatocellular carcinoma.
    Sheng XR; Xing SG; Wang RD; Chen K; Jia WD
    Onco Targets Ther; 2018; 11():909-917. PubMed ID: 29503566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoskeleton-associated membrane protein 4 is upregulated in tumor tissues and is associated with clinicopathological characteristics and prognosis in hepatocellular carcinoma.
    Chen ZY; Wang T; Gan X; Chen SH; He YT; Wang YQ; Zhang KH
    Oncol Lett; 2020 Jun; 19(6):3889-3898. PubMed ID: 32382336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of Diagnostic and Prognostic Value of CLEC4M of Non-Small Cell Lung Carcinoma Associated with Immune Microenvironment.
    Liu H; Yu Z; Liu Y; Li M; Chen C; Zhu Z; Liu F; Tan L
    Int J Gen Med; 2023; 16():1317-1332. PubMed ID: 37089135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High interleukin-8 and/or extracellular signal-regulated kinase 2 expression predicts poor prognosis in patients with hepatocellular carcinoma.
    Deng Y; Ning Z; Hu Z; Yu Q; He B; Hu G
    Oncol Lett; 2019 Nov; 18(5):5215-5224. PubMed ID: 31612032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of Sox3 is associated with promoted tumor progression and poor prognosis in hepatocellular carcinoma.
    Feng Y; Xiao F; Yang N; Zhu N; Fu Y; Zhang HB; Yang GS
    Int J Clin Exp Pathol; 2017; 10(7):7873-7881. PubMed ID: 31966635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical significance of RYBP expression in primary hepatocellular carcinoma].
    Jing X; Cai W; Huang B; Chen H; Chen D
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Apr; 44(4):399-405. PubMed ID: 31113915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of HOXA13 as a potential marker for diagnosis and poor prognosis of hepatocellular carcinoma.
    Pan TT; Jia WD; Yao QY; Sun QK; Ren WH; Huang M; Ma J; Li JS; Ma JL; Yu JH; Ge YS; Liu WB; Zhang CH; Xu GL
    Tohoku J Exp Med; 2014 Nov; 234(3):209-19. PubMed ID: 25341685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Expression of Neuropilin-1 Associates with Unfavorable Clinicopathological Features in Hepatocellular Carcinoma.
    Zhang Y; Liu P; Jiang Y; Dou X; Yan J; Ma C; Fan Q; Wang W; Su F; Tang H; Su X
    Pathol Oncol Res; 2016 Apr; 22(2):367-75. PubMed ID: 26563279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
    Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
    Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.